Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Alferon N Injection completes phase III in HIV

Dec. 12, 1997

EU approves ciclosporin bulk substance

Dec. 12, 1997

Alza and Warner-Lambert sign distribution agreement for nasal decongestant OTC

Dec. 12, 1997

FDA approves SERM for preventing postmenopausal osteoporosis

Dec. 11, 1997

Propecia recommended for approval for hair loss in men

Dec. 9, 1997

FDA approves shorter treatment claim for Mentax

Dec. 9, 1997

Another ANDA approval for Gensia

Dec. 8, 1997

SangStat signs ciclosporin agreement with Amgen

Dec. 8, 1997

Oncaspar approved in Canada

Dec. 5, 1997

Gensia Laboratories receives generic approval

Dec. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...